Storia in 12 fonti

AtaiBeckley: Eli Lilly kauft Psychedelika-Entwickler von Christian Angermayer

Psychedelische Substanzen versprechen offenbar gute Geschäfte. Jetzt kauft der Pharmakonzern Eli Lilly den US-Spezialisten AtaiBeckley für rund 4 Milliarden Dollar. Größter Atai-Aktionär ist der deutsche Investor Christian Angermayer.

Raccontata da

biopharmadive.com

benzinga.com

economictimes.indiatimes.com

www1.folha.uol.com.br

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

manager-magazin.deStai leggendo29 g fa

AtaiBeckley: Eli Lilly kauft Psychedelika-Entwickler von Christian Angermayer

originale

Timeline cronologica

giovedì 16 luglio 2026·biopharmadive.com
Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics
The latest in a prolific streak of buyouts by Lilly is the strongest sign yet that large pharmaceutical companies may finally be embracing a long-dismissed field of research.
giovedì 16 luglio 2026·benzinga.com
AtaiBeckley (ATAI) Stock Skyrockets 65% After-Hours on Eli Lilly Acquisition Talks - Eli Lilly (NYSE:LLY)
AtaiBeckley shares jumped 64.70% after hours following reports that Eli Lilly is in talks to acquire the psychedelic drugmaker at a premium.

AtaiBeckley: Eli Lilly kauft Psychedelika-Entwickler von Christian Angermayer

Confronto fonti

AtaiBeckley: Eli Lilly kauft Psychedelika-Entwickler von Christian Angermayer

Timeline cronologica

Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics

AtaiBeckley (ATAI) Stock Skyrockets 65% After-Hours on Eli Lilly Acquisition Talks - Eli Lilly (NYSE:LLY)

Pharma: Eli Lilly kauft Psychedelika-Entwickler AtaiBeckley

Eli Lilly punta sugli psichedelici: acquisirà AtaiBeckley per 2,8 miliardi di dollari | MilanoFinanza News

Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal

Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley

Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics

Weight-loss drugmaker Lilly nears $1.97 bn AtaiBeckley's acquisition: Report

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction

Lilly bets $2.8B upfront on psychedelics in deal to buy AtaiBeckley

Eli Lilly punta sugli psichedelici: acquisirà AtaiBeckley per 2,8 miliardi di dollari | MilanoFinanza News

Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley

Pharma: Eli Lilly kauft Psychedelika-Entwickler AtaiBeckley

Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal

Eli Lilly scommette sulla salute mentale: acquisita AtaiBeckley per 2,8 miliardi di dollari

AtaiBeckley: Eli Lilly kauft Psychedelika-Entwickler von Christian Angermayer

Eli Lilly agrees to $3.8B psychedelic buy

AtaiBeckley Shares Surge as Eli Lilly Seals $3.8B Acquisition Deal - Eli Lilly (NYSE:LLY), AtaiBeckley (N

Eli Lilly lancia opa su AtaiBeckley | MilanoFinanza News

Dona da Mounjaro compra empresa que produz antidepressivos por US$ 3,8 bilhões